02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
With the implementation of the Tax Cuts and Jobs Act of 2017, it was only a matter of time before th...
Read More >
The IRS has just issued the cost of living adjustments for various retirement plan limitations that ...
Read More >
The increasing and dynamic impact of the novel Coronavirus (COVID-19) is tangible. For example, on J...
Read More >
The coronavirus pandemic has weakened European economies and companies. EU and national governments ...
Read More >
In follow up to our previous posting regarding the June 11, 2019, delay to the start of the new Mass...
Read More >
The wait is over: This morning the NLRB announced that it will issue its final rule governing joint-...
Read More >